BiO2 Medical has received CE Mark approval for the Angel Catheter, a nitinol inferior vena cava (IVC) filter permanently attached to a central venous catheter, for the use of preventing pulmonary embolism in critically ill patients. The multi-lumen catheter can be used like a normal central venous system for administering medications, fluids or blood products, blood sampling and monitoring of central venous pressure. At the same time it provides pulmonary embolism prophylaxis by means of the attached IVC filter.
The primary patient population is critical care patients in whom anticoagulation therapy poses a high risk of complications, including major bleeding and death, and in which patients are at highest risk of venous thromboembolism (VTE). The filter can be easily removed when the central line is removed, once the danger of VTE has been resolved.
The combined central line/IVC filter makes placement easy as insertion is a bedside procedure not very different from normal central line placement and guarantees the filter is truly temporary as it slides out along with central line removal. Moreover, the design eliminates some of the potential complications of traditional IVC’s: vena cava perforation caused by hooks, filter tilting, filter migration, and irretrievability.
Press release: BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication…
Product page: Angel Catheter…
